Compare CVS Health Corp (CVS) vs Edwards Lifesciences Corporation Common Stock (EW) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
CVS Health Corp vs Edwards Lifesciences Corporation Common Stock — how do they compare? CVS Health Corp trades at $85.29 (market cap $112.29B), while Edwards Lifesciences Corporation Common Stock trades at $84.24 (market cap $48.56B). The key difference: CVS Health Corp is far larger — about 2.3× Edwards Lifesciences Corporation Common Stock's market cap, and CVS Health Corp pays a 3.03% dividend while Edwards Lifesciences Corporation Common Stock pays none. Which is the better fit depends on your goals.
| CVS | EW | |
|---|---|---|
Market Cap | $112.29B | $48.56B |
Volume | 7,763,676 | 6,520,488 |
Sector | Health | Health |
52-Week High | $110.60 | $95.18 |
52-Week Low | $70.08 | $72.65 |
Typical Hold Time | 83 Days | — |
Enterprise Value | $174.64B | $45.01B |
Dividend Yield | 3.03% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
CVS Health trades at $87.95, up 1.76% with strong analyst support (85% buy ratings) and a $111.20 consensus price target suggesting 26% upside. Recent quarterly earnings consistently beat expectations, with Q2 2026 EPS of $2.58 surpassing the $1.85 estimate. Revenue growth remains solid at $402.07 billion for 2025, though net margins compressed to 1.18%. Technical indicators show a bullish overall signal with support at $87 and resistance at $89.
The outlook remains positive given CVS's dominant market position and Medicare expansion plans, but investors face risks from reimbursement pressures and ongoing legal investigations. Earnings growth and successful execution of healthcare services integration represent the primary catalysts for continued stock appreciation.
No Aura AI signal available yet.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About CVS Health Corp
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with 24 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
Read more on CVS →About Edwards Lifesciences Corporation Common Stock
Edwards Lifesciences develops medical technologies for structural heart disease. Its products include transcatheter aortic-valve replacement, mitral and tricuspid therapies, and surgical structural-heart technologies.
Read more on EW →
